++
+++
Essentials of Diagnosis
++
Distinction in acute coronary syndrome (ACS) between patients with and without ST-segment elevation at presentation is essential to determine need for reperfusion therapy
Fibrinolytic therapy is harmful in ACS without ST-segment elevation, unlike with ST-segment elevation where acute reperfusion saves lives
Antiplatelet and anticoagulation therapies and coronary intervention are mainstays of treatment
+++
General Considerations
++
Acute coronary syndromes comprise the spectrum of unstable cardiac ischemia from unstable angina to myocardial infarction (MI)
Acute coronary syndromes are classified based on the presenting ECG as either "ST-segment elevation" (STEMI) or "non–ST-segment elevation"
The evolution of cardiac biomarkers allows determination of whether MI has occurred
The universal definition of MI is a rise of cardiac biomarkers with at least one value above the 99th percentile of the upper reference limit together with evidence of myocardial ischemia with at least one of the following:
Acute coronary syndromes represent a dynamic state in which patients frequently shift from one category to another, as new ST elevation can develop after presentation and cardiac biomarkers can become abnormal with recurrent ischemic episodes
++
Angina occurs at rest or with minimal exertion
Substernal chest pain or discomfort that may radiate to the jaw, left shoulder, or arm
Dyspnea, nausea, diaphoresis or syncope may either accompany the chest discomfort or may be the only symptom of ACS
About one-third of patients with MI have no chest pain per se—these patients tend to be older, female, have diabetes, and be at higher risk for subsequent mortality
Patients with ACS have signs of heart failure in about 10% of cases, and this is also associated with higher risk of death
+++
Differential Diagnosis
++
++
Depending on the time from symptom onset to presentation, initial laboratory findings may be normal
Cardiac myocyte necrosis, myoglobin, creatine kinase (CK)-MB, and troponin I and T may all be used to identify acute MI
In patients with STEMI, these initial markers are often within normal limits as the patient is being rushed to immediate reperfusion
In patients without ST-segment elevation, it is the presence of abnormal CK-MB or troponin values that are associated with myocyte necrosis and the diagnosis of MI
High-sensitivity troponin assays allow rapid sex-based rule out algorithms for MI in emergency departments
Serum creatinine is an important determinant ...